Campaign Spoofs Big Pharma’s Direct-to-Consumer (DTC) Ads While Highlighting
Their Patent Abuse and Price Gouging Practices That Keep Prescription Drug
Prices High





 



CSRXP LAUNCHES SIX-FIGURE ADVERTISING CAMPAIGN TO HOLD BIG PHARMA ACCOUNTABLE
FOR ANTICOMPETITIVE PRACTICES AND EGREGIOUS DRUG PRICING

Campaign Spoofs Big Pharma’s Direct-to-Consumer (DTC) Ads While Highlighting
Their Patent Abuse and Price Gouging Practices That Keep Prescription Drug
Prices High



For Immediate Release

April 28, 2025



Contact: Jon Conradi

[email protected] <mailto:[email protected]>



Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) announced
the launch of a new six-figure advertising campaign Monday highlighting how Big
Pharma’s pricing practices, anti-competitive tactics and massive spending on
direct-to-consumer (DTC) advertising are the root cause of high prescription
drug prices in America.



“CSRxP’s new campaign invokes Big Pharma’s own imagery to highlight how the
pharmaceutical industry games the system to block competition, keep drug prices
high and increase sales of high-priced blockbuster products by spending
billions of dollars each year on advertising directly targeting consumers,”
said CSRxP executive director Lauren Aronson. “Congress and the Administration
should act on growing bipartisan support for holding Big Pharma accountable for
patent abuse and aggressive marketing practices that undermine competition from
more affordable alternatives, keep drug prices high and cost the American
people billions of dollars each year.”



The campaign follows the recent release of a report
<[link removed]>
conducted by CSRxP which found Big Pharma’s DTC ad spending costs U.S.
taxpayers billions of dollars each year, due to the combined impact of
increasing utilization and the pharmaceutical industry’s practice of writing
off marketing expenses from business taxes, to further pad their bottom line.



CSRxP’s campaign will start with a two-month, six-figure flight of video and
display advertising in Washington, D.C. See the ads here:



Watch the ad “Max Profitrexil” HERE
<[link removed]>.



Watch the ad “Patent Abuserol” HERE <[link removed]>.



Read CSRxP’s recent report on the cost of Big Pharma’s DTC advertising HERE
<[link removed]>
.



Read more on bipartisan, market-based solutions to lower drug prices by
holding Big Pharma accountable for anti-competitive abuse of the U.S. patent
systemHERE
<[link removed]>
.



Read more on additional bipartisan, market-based solutions to hold Big Pharma
accountableHERE <[link removed]>.



###

































Copyright © 2019 Campaign for Sustainable Rx Pricing
Our address is 1341 G St NW, #1100, Washington, DC xxxxxx


This email was sent to [email protected]. To unsubscribe please click
here.
<[link removed]>